Clinical Roundup GRAIL presents PATHFINDER multi-cancer early detection screening study results September 16, 2022Vol.48 No.33
Clinical Roundup Novartis’ Kisqali provides additional year of survival benefit, including for aggressive HR+/HER2- advanced breast cancer September 16, 2022Vol.48 No.33
Clinical Roundup Zejula shows durable, sustained long-term PFS benefit in first-line platinum-responsive advanced ovarian cancer September 16, 2022Vol.48 No.33
Clinical Roundup Study shows specific sequence of drugs reduces cost of treating metastatic breast cancer while preserving quality of life September 16, 2022Vol.48 No.33
Clinical Roundup Strata Oncology expands Strata PATH trial to eight Sarah Cannon Research Institute sites September 16, 2022Vol.48 No.33
Clinical Roundup The WiTT Group and Mary Crowley Cancer Research form partership to enhance access to clinical trials September 16, 2022Vol.48 No.33
Clinical Roundup Pralsetinib achieves tissue-agnostic benefits for patients with RET gene fusions September 16, 2022Vol.48 No.33
Clinical Roundup Phase III study of Cytalux injection for intraoperative imaging of ovarian cancer shows identification of additional lesions September 16, 2022Vol.48 No.33
Clinical Roundup NCI study shows physical activities may lower risk of death for older adults September 09, 2022Vol.48 No.32
Clinical Roundup Higher doses of CAR T-cell therapy bring survival advantage for young patients with hard-to-treat B-ALL September 09, 2022Vol.48 No.32
